StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed cash

Cash and short-term investments held at the end of each period.

CervoMed's cash was $24.90M at Jun 30, 2026. For fiscal 2025 it was $20.90M, down 46.3% from the year before. Over ten years it grew 26.5% a year on average. The highest annual figure on record is $38.92M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.90M-46.3%
FY2024Dec 31, 2024$38.92M+399.5%
FY2023Dec 31, 2023$7.79M-52.8%
FY2022Dec 31, 2022$16.50M+147.5%
FY2021Dec 31, 2021$6.67M-64.0%
FY2020Dec 31, 2020$18.52M+30.6%
FY2019Dec 31, 2019$14.18M+77.4%
FY2018Dec 31, 2018$7.99M-10.2%
FY2017Dec 31, 2017$8.90M+472.9%
FY2016Dec 31, 2016$1.55M-22.2%
FY2015Dec 31, 2015$2.00M-14.5%
FY2014Dec 31, 2014$2.34M+816.4%
FY2013Dec 31, 2013$254.96K-18.3%
FY2012Dec 31, 2012$312.09K+217.0%
FY2011Dec 31, 2011$98.45K–
FY2010Dec 31, 2010$0–
FY2009Dec 31, 2009$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$24.90M-25.7%
Q1 FY2026Mar 31, 2026$12.90M-63.4%
Q4 FY2025Dec 31, 2025$20.90M-46.3%
Q3 FY2025Sep 30, 2025$27.30M-41.5%
Q2 FY2025Jun 30, 2025$33.50M-25.7%
Q1 FY2025Mar 31, 2025$35.24M+453.4%
Q4 FY2024Dec 31, 2024$38.92M+399.5%
Q3 FY2024Sep 30, 2024$46.66M+347.6%
Q2 FY2024Jun 30, 2024$45.09M+6839.5%
Q1 FY2024Mar 31, 2024$6.37M+13.7%
Q4 FY2023Dec 31, 2023$7.79M-52.8%
Q3 FY2023Sep 30, 2023$10.42M-56.7%
Q2 FY2023Jun 30, 2023$649.78K-97.7%
Q1 FY2023Mar 31, 2023$5.60M-82.8%
Q4 FY2022Dec 31, 2022$16.50M+147.5%
Q3 FY2022Sep 30, 2022$24.06M-40.4%
Q2 FY2022Jun 30, 2022$28.54M-34.1%
Q1 FY2022Mar 31, 2022$32.55M-30.2%
Q4 FY2021Dec 31, 2021$6.67M-64.0%
Q3 FY2021Sep 30, 2021$40.34M+84.1%
Q2 FY2021Jun 30, 2021$43.31M+69.4%
Q1 FY2021Mar 31, 2021$46.63M+330.7%
Q4 FY2020Dec 31, 2020$18.52M+30.6%
Q3 FY2020Sep 30, 2020$21.91M+256.9%
Q2 FY2020Jun 30, 2020$25.56M+205.3%
Q1 FY2020Mar 31, 2020$10.83M+103.0%
Q4 FY2019Dec 31, 2019$14.18M+77.4%
Q3 FY2019Sep 30, 2019$6.14M-44.3%
Q2 FY2019Jun 30, 2019$8.37M-35.3%
Q1 FY2019Mar 31, 2019$5.33M-67.1%
Q4 FY2018Dec 31, 2018$7.99M-10.2%
Q3 FY2018Sep 30, 2018$11.02M+806.1%
Q2 FY2018Jun 30, 2018$12.93M+74.5%
Q1 FY2018Mar 31, 2018$16.20M+32.7%
Q4 FY2017Dec 31, 2017$8.90M+472.9%
Q3 FY2017Sep 30, 2017$1.22M-59.8%
Q2 FY2017Jun 30, 2017$7.41M–
Q1 FY2017Mar 31, 2017$12.21M–
Q4 FY2016Dec 31, 2016$1.55M–
Q3 FY2016Sep 30, 2016$3.02M–

More CervoMed figures

See a number that looks wrong?